RE:RE:Cormack analyst
SWYG, Oh, I'm sure you will give us your take on what has been said. You are so enlightened, you think you are JC. The exact words were: "Maintaining Buy (S) Recommendation, $1.50 Target We reiterate the speculative, high risk nature of this investment, considering the conflicting evidence regarding Toraymyxin efficacy in the scientific domain, in addition to the mortality assumptions made post protocol amendment." I can't provide a link but if you ask IR for a copy I'm sure they will pass it along. GO FOR IT SWYG. You've been whinging that there has been no coverage and now there is, you're whinging again. You are never happy with the way things are. You think I'm bashing. FU! I just provide information and ask questions to get information. You overburden us with your diatribe/BS/schizoid view!! We wait with baited!! breath for your in depth analysis.